How Long Does It Take for a Monovisc Cartilage Injection to Work?
Insights

How Long Does It Take for a Monovisc Cartilage Injection to Work?

London Cartilage Clinic

Monovisc injections represent a significant advancement in the treatment of knee cartilage issues, offering hope to those suffering from osteoarthritis and similar conditions. This hyaluronic acid-based treatment aims to improve joint lubrication, reduce pain, and enhance mobility. Given its importance, many patients are keen to understand how long it takes for a Monovisc injection to start showing results. This article provides a comprehensive overview, tailored to those exploring their treatment options at the London cartilage Clinic.

Understanding Monovisc Cartilage Injections

Monovisc is a single-injection treatment designed to supplement the viscous properties of the synovial fluid in the knee, thereby improving its lubricating function and cushioning ability. This non-surgical option is particularly beneficial for patients with knee osteoarthritis, aiming to alleviate pain and improve joint mobility.

How the Injection Works

Monovisc's primary component, hyaluronic acid, closely mimics the naturally occurring synovial fluid within the joints. When injected into the knee, it integrates with the existing synovial fluid, enhancing its thickness and lubricating properties. This process helps to reduce friction and wear on the cartilage, providing pain relief and improved joint function.

Factors Affecting the Time Taken to Work

The time it takes for Monovisc injections to show their effects can vary significantly among individuals, influenced by several factors, including:

  • The severity of the cartilage degradation or osteoarthritis.
  • The individual's activity level and lifestyle.
  • The overall health and age of the patient.
  • Compliance with post-injection care and rehabilitation recommendations.

Who Will Benefit from the Treatment?

Monovisc injections are most suitable for individuals experiencing mild to moderate osteoarthritis symptoms in the knee. Ideal candidates are those seeking to manage their symptoms with non-surgical options and have not found adequate relief from oral pain medications or physical therapy.

Benefits and Drawbacks

Benefits:

  • Non-surgical and minimally invasive with no downtime.
  • Provides lubrication and cushioning to the knee joint, potentially delaying the need for knee replacement surgery.
  • Suitable for patients with allergies to avian-based hyaluronic acid products.

Drawbacks:

  • Results and their duration can vary between individuals.
  • Some patients may experience temporary injection site pain or swelling.
  • Not a cure for osteoarthritis but a treatment to manage symptoms.

In summary, Monovisc cartilage injections offer a promising avenue for alleviating knee pain and improving joint function in individuals with osteoarthritis. The time to experience relief can vary, but most patients report noticeable improvements within the first month after treatment. As with any medical intervention, discussing your specific situation with a healthcare provider at London Cartilage Clinic is crucial to determine if Monovisc is the right option for you. Our commitment is to provide you with the highest standard of care, tailoring treatment plans to meet your unique needs and help you return to your preferred lifestyle. Book a Consultation

Frequently Asked Questions

  • Most patients begin to notice improvements within a few days to a few weeks post-injection, with significant relief typically observed within a month.
  • The duration of pain relief varies, but many patients report experiencing benefits for up to six months following the treatment.
  • While generally well-tolerated, some individuals may experience mild side effects such as injection site pain, swelling, or stiffness, which usually subside within a few days.
  • Monovisc is typically recommended for mild to moderate osteoarthritis. Patients with severe osteoarthritis may need to explore other treatment options.
  • Light to moderate activities are encouraged as they can promote joint health. However, it's advisable to avoid strenuous activities for the first few days post-injection.
  • While the effects can last up to six months, treatment can be repeated as necessary, following consultation with a healthcare professional.

Where to go from here

A few next steps tailored to what you have just read.

Legal & Medical Disclaimer

This article is written by an independent contributor and reflects their own views and experience, not necessarily those of London Cartilage Clinic. It is provided for general information and education only and does not constitute medical advice, diagnosis, or treatment.

Always seek personalised advice from a qualified healthcare professional before making decisions about your health. London Cartilage Clinic accepts no responsibility for errors, omissions, third-party content, or any loss, damage, or injury arising from reliance on this material.

If you believe this article contains inaccurate or infringing content, please contact us at [email protected].

Last reviewed: 2026For urgent medical concerns, contact your local emergency services.

London Cartilage Clinic

Latest Insights

Clinical updates, cartilage treatment guidance, and recovery-focused articles from our specialist team.

Why Athletes Choose OATS Over Microfracture
Knee Cartilage Repair
Eleanor Hayes

Why Athletes Choose OATS Over Microfracture

OATS transplants the patient's own hyaline cartilage into the knee joint; microfracture draws marrow cells that form fibrocartilage — softer, less durable tissue. For athletes in high-impact sport, the difference is decisive: 93% return to sport after OATS versus roughly 50% after microfracture.

How Long ChondroFiller™ Injection Results Last
ChondroFiller / Liquid Cartilage
Eleanor Hayes

How Long ChondroFiller™ Injection Results Last

Because the injected collagen scaffold resorbs entirely and is replaced by the patient's own hyaline-like cartilage, ChondroFiller™ produces lasting functional repair rather than temporary symptom masking—explaining why 70–85% of patients sustain near-normal knee function at three years.

Privacy & Cookies Policy